Penglei Ge

853 citations
17 papers · 607 indexed · h-index 11
Topics
Liver Disease Diagnosis and Treatment (5 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)Liver Disease and Transplantation (3 papers)
Partner nations
ChinaIsraelCanada

In The Last Decade

Penglei Ge

17 papers receiving 597 citations

Peers

Penglei Ge
Comparison fields: 5 of 78
  • Oncology 211
  • Cancer Research 192
  • Pulmonary and Respiratory Medicine 189
  • Hepatology 167
  • Molecular Biology 151
Replace Panagis M. Lykoudis with:
Panagis M. Lykoudis Greece
Yukio Sugimasa Japan
Kenya Yamanaka Japan
Yusuke Kumamoto Japan
Lun‐Jie Yan China
Naohiro Hosomura Japan
Feng Shi China
Jesús Méndez‐González Spain
Takashi Kizu Japan
Wenda Li China
Penglei Ge relative to Panagis M. Lykoudis Greece Panagis M. Lykoudis's profile →
Citations per field
00.5×1.5×
Panagis M. Lykoudis · 1×
Citations per year

Countries citing papers authored by Penglei Ge

Since Specialization
Citations

This map shows the geographic impact of Penglei Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penglei Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penglei Ge more than expected).

Fields of papers citing papers by Penglei Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Penglei Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penglei Ge. The network helps show where Penglei Ge may publish in the future.

Co-authorship network of co-authors of Penglei Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Penglei Ge. A scholar is included among the top collaborators of Penglei Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Penglei Ge. Penglei Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 1
2 4
3 1
4 7
5 27
6 172
7 98
8 31
9 17
10 10
11 1
12 95
13 15
14 13
15 55
16 59
17
[Effect of glucagon-like peptide-2 (GLP-2) on intestinal barrier function in bile duct ligated rats].
1

About Penglei Ge

Penglei Ge is a scholar working on Hepatology, Pathology and Forensic Medicine and Cancer Research, having authored 17 papers that have together received 607 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Liver Disease and Transplantation (3 papers). The work is most often cited by research in Hepatology (167 citations), Cancer Research (192 citations) and Oncology (211 citations). Penglei Ge has collaborated with scholars based in China, Israel and Canada. Frequent co-authors include Yilei Mao, Huayu Yang, Xiaowei Dang, Weiwei Wang, Lin Li, Yang Wu, Wenjun Liao, Xinting Sang, Shouxian Zhong and Zhiqiang Gao. Their work appears in journals such as Medicine, Oncotarget and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026